Skip to main content

Table 1 Multivariate Regression for Prediction of LV MWF

From: Mid-wall fibrosis on delayed enhancement CMR - a marker for adverse left ventricular chamber remodeling independent of cardiomyopathic etiology

1A. Imaging (Model χ2 = 26.0, p < 0.001)   
Variable Odds Ratio 95% Confidence Interval P
LV Ejection Fraction (per 10% decrement) 1.46 1.03-2.10 < 0.05
LV End-Diastolic Volume (per 10 ml/m2) 1.13 1.04-1.20 < 0.05
Myocardial Mass (per 10 gm/m2) 0.95 0.85-1.00 0.29
1B. Clinical (Model χ2 = 76.7, p < 0.001)   
Variable Odds Ratio 95% Confidence Interval P
Hypertension 0.10 0.36 - 1.10 0.10
Hypercholesterolemia 0.94 0.59 - 1.78 0.94
Age (years) 0.70 0.99 - 1.00 0.70
Non-Ischemic Etiology 8.4 4.78- 14.72 < 0.001
1C. Integrated Clinical/Imaging (Model χ2 = 91.2, p < 0.001)   
Variable Odds Ratio 95% Confidence Interval P
LV Ejection Fraction (per 10% decrement) 1.22 0.84- 1.78 0.29
LV End-Diastolic Volume (10 ml/m2) 1.11 1.03 - 1.20 < 0.05
Non-Ischemic Etiology 8.22 4.75 - 14.2 < 0.001